Dutch immunotherapy company ISA Pharmaceuticals has closed a €26m funding round that will go towards advancing...
Up To Date
Latest News
As part of its 'Clean Future' strategy, Unilever NV has licensed enzyme technology from Arzeda Inc. to help...
Danish Novo Nordisk is moving out of the diabetes space and taking over Prothena’s ATTR amyloidosis programme...
Sanofi is shelling out US$1bn for a license granting the French pharma company access to a potential multiple...
Oslo-based microbiome expert Bio-Me A/S has raised NOK10m in a new funding round.
French biopharma company NFL Biosciences has raised €5m following its IPO at Euronext Growth Paris.